AP

Clinical trials for AP explained in plain language.

Never miss a new study

Get alerted when new AP trials appear

Sign up with your email to follow new studies for AP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New antibiotic cocktails take on tough UTIs and kidney infections

Disease control Completed

This phase 3 trial tested two new antibiotic combinations—cefepime/nacubactam and aztreonam/nacubactam—against a standard antibiotic (imipenem/cilastatin) in 614 adults with complicated urinary tract infections or acute kidney infections. The goal was to see if the new combos are…

Matched conditions: AP

Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

AP

Get alerted when new AP trials appear

New antibiotic cocktails take on tough UTIs and kidney infections